The Role of Endothelial Microparticle in Coronary Heart Disease as The Complications of Diabetes Mellitus
DOI:
https://doi.org/10.15575/biodjati.v4i1.4164Keywords:
coronary heart disease, diabetes mellitus, endothelial dysfunction, endothelial nitric oxide synthase, nitric oxideAbstract
Â
 Coronary heart disease (CHD) is caused by obstruction of coronary blood flow due to endothelial dysfunction triggered by various genetic and non-genetic risk factors such as hyperlipidemia, hypertension, hyperglycemia and obesity. Endothelial cell activation due to hyperglycaemia in diabetes mellitus induces production of pro-inflammatory factors that damage the cell membrane triggering the formation of membrane particles called microparticles. Endothe-lial microparticles contain proteins including endothelial nitric oxide synthase (eNOS) which plays a role in the production of nitric oxide (NO). To determine the role of microparticles in the occurrence of coro-nary heart disease in diabetes mellitus due to endothelial dysfunction, a study was conducted by comparing the levels of eNOS and NO in DM patients who had CHD with DM patients who had no CHD. Blood samples from 20 DM patients who had CHD and 20 DM patients who had no CHD of the outpatients in Cardiology Department and Inter-nal Medicine department of regional public hospital were included in this study. All patients were fulfilled inclusion and exclusion criteria and diagnosed by the appropriate specialist. The eNOS and NO lev-els were measured using the ELISA method. The results of this study show that eNOS levels in the group of DM patients who had CHD (21,292±12,415 ng/ml) were significantly lower (p <0.05) than those in the group of DM patients who had no CHD (29,721±11,952 ng/ml). Nitric oxide levels in DM patients who had CHD (0,053±0,021 nmol/ μl) were not statistically different to the levels in DM patients who had no CHD (0,047±0,032 nmol/μl). From the results of this study we concluded that endothelial microparticle protein eNOS plays a role in the occurrence of CHD due to the complications of diabetes mellitusÂ
References
Adela, R., Nethi, S. K., Bagul, P. K., Barui, A. K., Mattapally, S., Kuncha, M., Patra, C. R., Reddy, P. N. & Banerjee, S. K. (2001). Hyperglycaemia Enhanc-es Nitric Oxide Production in Diabetes: A Study from South Indian Patients. PLOS ONE, 10(4), 1-7.
Agouni, A., Lagrue-Lak-Hal, A. H., Ducluzeau, P. H., Mostefai, H. A., Draunet-Busson, C., Leftheriotis, G., Heymes, C., Martinez, M. C. & An-driantsitohaina, R. (2008). Endotheli-al Dysfunction Caused by Circulating Microparticles from Patients with Met-abolic Syndrome. Am J Pathol, 173, 1210-1219.
Ali, M. K., Narayan, K. M. V. & Tandon, N. (2010). Diabetes & Coronary Heart Disease: Current Perspectives. Indian J Med Res, 132(5), 584–597.
Aronson, D. & Edelman, E. R. (2014). Coro-nary Artery Disease and Diabetes Melli-tus. Cardiol Clin, 32(3), 439–455.
Assman, T. A., Bouças, A. P., Rheinheimer, R., de Souza, B. M., Canani, L. H., Bau-er, A. C. & Crispim, D. (2016). Nitric Oxide Levels in Patients with Diabetes Mellitus: A systematic review and me-ta-analysis. Nitric Oxide, 61, 1-9.
Avogaro, A., Albiero, M., Menegazzo, L., de Kreutzenberg, S. & Fadini, G. P. (2011). Endothelial Dysfunction in Diabetes: The Role of Reparatory Mechanisms. Diabetes Care, 34 (Suppl 2), 285-290.
Calles-Escandon, J. & Cipolla, M. (2001). Diabetes and Endothelial Dysfunction: a Clinical Perspective. Endocrine re-views, 22(1), 36-52.
Deanfield, J. E., Halcox, J. P. & Rabelink, T. J. (2007). Endothelial Function and Dysfunction: Testing and Clinical Rele-vance. Circulation, 115, 1285-1295.
Dignat-George, F. & Boulanger, C. M. (2011). The Many Faces of Endothelial Mi-croparticles. Arterioscler Thromb Vasc Biol, 31, 27-33.
Esper, R. J., Nordaby, R. A., Vilarino, J. O., Paragano, A., Cacharron, J. L. & Macha-do, R. A. (2006). Endothelial dysfunc-tion: a comprehensive review. Cardio-vascular Diabetology, 5(4), 1-18.
Förstermann, U. & Münzel, T. (2006). En-dothelial Nitric Oxide Synthase in Vas-cular Disease. From Marvel to Menace. Circulation, 113, 1708–1714.
Förstermann, U. (2010). Nitric oxide and Oxidative Stress in Vascular Disease. Pflugers Arch., 459(6), 923-939.
Funk, S. D., Yurdagul, Yr. A. & Orr, A. W. (2014). Hyperglycemia and Endotheli-al Dysfunction in Atherosclerosis: Les-sons from Type 1 Diabetes. Int J Vasc Med., 1-19.
Hansson, G. K. (2005). Inflammation, Athero-sclerosis, and Coronary Artery Disease. NEJM., 352, 1685-1695.
Hasnawati, Sugito, Purwanto, H. & Ibrahim, R. (2009). Profil kesehatan indonesia 2008. Jakarta: Departemen Kesehatan Republik Indonesia.
Helbing, T., Olivier, C., Bode, C., Moser, M. & Diehl, P. (2014). Role of Micropar-ticles in Endothelial Dysfunction and Arterial Hypertension. World J Cardiol, 6(11), 1135-1139
Horn, P., Cortese-Krott, M. M., Amabile, N., Hundsdörfer, C., Kröncke, K. D., Kelm, M. & Heiss C. (2013). Circulating Microparticles Carry a Functional En-dothelial Nitric Oxide Synthase That Is Decreased in Patients With Endothelial Dysfunction. J Am Heart Assoc., 2(1), 756-768.
Libby, P. (2012). Inflammation in atheroscle-rosis. Arterioscler Thromb Vasc Biol., 32, 2045–2051.
Lopez, A., Mathers, C., Ezzati, M., Jamison, D. & Murray, C. (2006). Global Burden of Disease and Risk Factors. New York: World Bank Group.
Lovren, F. & Verma, S. (2013). Evolving Role of Microparticles in the Pathophysiolo-gy of Endothelial Dysfunction. Clinical Chemistry, 59(8), 1166-1174.
Mahmoud, A. M., Wilkinson, F. L., McCar-thy, E. M., Moreno-Martinez, D., Lang-ford-Smith, A., Romero, M, Duarte, J. & Alexander, M. Y. (2017). Endothelial Microparticles Prevent Lipid-Induced Endothelial Damage Via Akt/eNOS Sig-naling and Reduced Oxidative Stress. FASEB J, 31(10), 4636–4648.
Martinez, M. C., Tesse, A., Zobairi, F. & An-driantsitohaina, R. (2005). Shed Mem-brane Microparticles from Circulating and Vascular Cells in Regulating Vascu-lar Function. Am J Physiol Heart Circ Physiol, 288, 278-288.
Matheus, A. S., Tannus, L. R., Cobas, R. A., Palma, C. C., Negrato, C. A. & Gomes, M. B. (2013). Impact of Diabetes on Cardiovascular Disease: an Update. International Journal of Hypertension, 20(13), 1-15.
Owens, A. P. & Mackman, N. (2011). Mi-croparticles in Hemostasis and Throm-bosis. Circ Res, 108(10), 1284-97.
Packard, R. R. S. & Libby, P. (2008). Inflam-mation in Atherosclerosis: from Vascu-lar Biology to Biomarker Discovery and Risk Prediction. Clinical Chemistry, 54, 24-38
Sayols-Baixeras, S., LluÃs-Ganella, C., Lucas, G. & Elosua, R. (2014). Pathogenesis of Coronary Artery Disease: Focus on Genetic Risk Factors and Identification of Genetic Variants. Appl Clin Genet, 7, 15–32.
Schiro, A., Wilkinson, F. L., Weston, R., Smyth, J. V., Serracino-Inglott, F. & Al-exander, M. Y. (2014). Endothelial mi-croparticles as conveyor of information
in atherosclerotic disease. Atherosclero-sis, 234: 295-302.
Shi, F., Wang, Y. C., Zhao, T. Z., Zhang, S., Du, T. Y., Yang, C. B., Li, Y. H. & Sun, X. Q. (2012). Effects of simulated mi-crogravity on human umbilical vein en-dothelial cell angiogenesis and role of the PI3K-Akt-eNOS signal pathway. PLoS ONE, 7(7).
Tramontano, A. F., Lyubarova, R., Tsiakos, J., Palaia, T., DeLeon, J. R. & Ragolia, L. (2010). Circulating Endothelial Mi-croparticles in Diabetes Mellitus. Medi-ators of inflammation, 2010, 1-8.
Tripathi, P., Tripathi, P., Kashyap, L. & Singh, V. (2007). The Role of Nitric Oxide in Inflammatory Reactions. FEMS Immu-nology & Medical Microbiology, 51(3), 443–452.
Van de Oever, I. A. M., Raterman, H. G., Nur-mohamed, M. T. & Simsek, S. (2010). Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus. Me-diators of Inflammation, 20(10), 1-15.
Vapaatalo, H. & Mervaala, E. (2001). Clin-ically Important Factors Influencing Endothelial function. Med Sci Monit, 7(10), 75–85.
Vidigal, F. de. C., Cocate, P. G., Pereira, L. G., Alfenas R. de. C. G. (2012). The Role of Hyperglycemia in the Induction of Oxi-dative Stress and Inflammatory Process. Nutr Hosp., 27(5), 1391-1398.
World Health Organization (WHO). (2008). The Global Burden of Disease: 2004 update. World Health Organization Int. Geneva.
Downloads
Published
How to Cite
Issue
Section
Citation Check
License
Copyright and Attribution:
Copyright of published in Jurnal Biodjati is held by the journal under Creative Commons Attribution (CC-BY-NC-ND) copyright. The journal lets others distribute and copy the article, create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as an tranlation), include in collective works (such as an anrhology), text or data mine the article, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article and do not modify the article in such a way as to damage the author's honor or reputation.
Permissions:
Authors wishing to include figures, tables, or text passages that have already been published elsewhere and by other authors are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate of one of the authors.
Ethical matters:
Experiments with animals or involving human patients must have had prior approval from the appropriate ethics committee. A statement to this effect should be provided within the text at the appropriate place. Experiments involving plants or microorganisms taken from countries other than the authors own must have had the correct authorization for this exportation.
